ORDER DENYING MOTION TO DISMISS
THIS CAUSE is before the Court on Defendant’s Motion to Dismiss Complaint in Its Entirety and Incorporated Memorandum of Law [DE 20] (“Motion to Dismiss”). The Court has considered the Motion to Dismiss, Plaintiffs Response [DE 25], Defendant’s Reply [DE 26], the record in this case, and is otherwise advised in the premises. 1
I. BACKGROUND
This case centers on Wm. Wrigley Jr. Company’s (‘Wrigley”) claim “that its Eclipse® gum brand is ‘scientifically proven to help kill the germs that cause bad breath’ as a result of thе ‘natural ingredient,’ Magnolia Bark Extract (‘MBE’)”. Compl. ¶ 3. Plaintiff alleges that “[t]his claim is false, deceptive and likely to mislead.” Id.
In June 2008, “Wrigley released a reformulated version of Eclipse® gum and touted it as ‘the first and only brand to include Magnolia Bark Extract, a natural ingredient scientifically proven to kill the germs that cause bad breath.’ ” Id. ¶ 12. The Complaint alleges that “Wrigley has engaged in an extensive and comprehensivе nationwide advertising campaign, spending millions of dollars to convey this deceptive message to consumers throughout the United States.” Id. ¶ 5. The Complaint contains several examples of Wrigley’s allegedly false advertising, including statements contained on the packaging. See id. ¶¶ 13-15.
Plaintiff states that “[i]n furtherance of its fraudulent and deceptive scheme, Wrigley attempts to pass off approximately nine irrelеvant or inadequate studies, claiming that they constitute ‘scientific proof.’ None of these studies, taken separately or in total, substantiate Wrigley’s claim.”
Id.
¶ 21. In support of this allegation, Plaintiff points to a study performed by the National Advertising Divi
Plaintiff asserts that “as a result of this deceptive advertising campaign,” Wrigley (1) “has elevated Eclipse® gum into one of the top sellers in the product category,” id. ¶ 6; and (2) “has been able to charge a premium price for Eclipse® gum over other chewing gum products, including other Wrigley chewing gum products.” Id. ¶ 7.
Plaintiff brings two causes of action on behalf of a putative class of Eclipse gum purchasers within the State of Florida.
Count I of the Complaint asserts a clаim under Florida’s Deceptive and Unfair Trade Practices Act, Fla. Stat. §§ 501.201 et seq., (“FDUTPA”), alleging, among other things, that “Plaintiff and the Class have been aggrieved by Wrigley’s unfair and deceptive practices in that they paid for Eclipse® gum.” [Compl. ¶¶ 49-58]. Count II of the Complaint asserts a claim for breach of express warranty in that ... Wrigley falsely warrants that Eclipse® gum is “scientifically proven” to help kill germs that cause bad breath. [Comрl. ¶¶ 59-63],
DE 25 at 1.
Defendant filed the instant Motion seeking dismissal of the Complaint in its entirety. Defendant argues that Plaintiffs FDUTPA claim “fails as a matter of law because the Complaint makes only conclusory allegations that advertising statements about Wrigley Eclipse gum caused her to suffer ‘actual damages’ or be ‘aggrieved.’ ” DE 20 ¶ 1. Next, Defendant argues that Plaintiffs claim for breach of express warranty fails for two independent reаsons: (1) Plaintiff is not “in privity” with Defendant, and (2) Plaintiff fails to allege a legally cognizable injury. Id. ¶ 2.
II. LEGAL STANDARD
In order to state a claim, Federal Rule of Civil Procedure 8(a)(2) requires “a short plain statement of the claim showing that the pleader is entitled to relief,” so as to “give the defendant fair notice of what the claim is and the grounds upon which it rests.”
Conley v. Gibson,
1. The Complaint States a Claim under FDUTPA
To state a claim for equitable relief under FDUTPA, Plaintiff must allege, at a minimum, that she has been aggrieved.
See Macias v. HBC of Florida, Inc.,
(1) Without regard to any other remedy or relief to which a person is entitlеd, anyone aggrieved by a violation of this part may bring an action to obtain a declaratory judgment that an act or practice violates this part and to enjoin a person who has violated, is violating, or is otherwise likely to violate this part.
(2) In any action brought by a person who has suffered a loss as a result of a violation of this part, such person may recover actual damages, plus attorney’s fees and court costs as provided in s. 501.2105. However, damages, fеes, or costs are not recoverable under this section against a retailer who has, in good faith, engaged in the dissemination of claims of a manufacturer or wholesaler without actual knowledge that it violated this part.
Fla. Stat. § 501.211 (emphasis added). Although there is some dispute between the parties regarding the distinction between these two standards, it is clear that “the statute made declaratory аnd injunctive relief available to a broader class of plaintiffs than could recover damages.”
Gritzke v. M.R.A. Holding, LLC,
No. 01-cv-495-RH,
“As a general rule, the measure of actual damages under [FDUTPA] is the difference in the market value of the product or serviсe in the condition in which it was delivered and its market value in the condition in which it should have been delivered.” 10A Fla. Jur.2d
Consumer and Borrower Protection
§ 172 (2009);
accord Rollins,
The Complaint alleges that “Plaintiff was exposed to and saw Wrigley’s advertising claims and purchased Eclipse® gum in reliance on these claims.” Compl. ¶ 9. The Complaint further alleges that “as a result of the misleading messages ..., Wrigley has been able to charge a price premium for Eclipse® gum.”
Id.
¶ 7. Ac
Defendant argues that Plaintiffs allegations are similar to those rejected by Judge Jordan in
Prohias v. Pfizer, Inc.,
Judge Jordan dismissed the plaintiffs’ FDUTPA claims finding that the complaint’s allegations failed to establish that plaintiffs were “aggrieved” or “suffered a loss.” Id. at 1335-38. Critical to the court’s holding was that the plaintiffs “still pay for Lipitor notwithstanding their knowledge of its alleged lack of benefits.” Id. at 1334 (emphasis in original). “[T]he fact that they currently take Lipitor, in light of the information they have, requires me to conclude that they take Lipitor for its cholesterol-reduction or other undisputed health benefits, and therefore cannot claim to have suffered any damage from the allegedly misleading statements about Lipitor’s coronary benefits.” Id. at 1336. There is no information before this Court that Plaintiff continues to pay for Eclipse gum despite knowledge that MBE is not “scientifically proven to help kill the germs that cause bad breath.” Compl. ¶ 3.
In
Prohias,
the court also did not accept plaintiffs’ argument that “they are injured within the meaning of the consumer fraud statutes ... because they paid a higher price for Lipitor than the market would have borne if not for Pfizer’s advertising scheme—specifically they allege ‘price inflation’ damages.”
Prohias,
In addition, Defendant relies on
Gorran v. Atkins Nutritionals, Inc.,
2. The Complaint States a Claim for Breach of Express Warranty
Defendant argues that Plaintiffs breach of warranty claim should be dismissed for failure to allege an injury.
See
DE 20 at 10-11. In order to state a claim for breach of warranty, the Plaintiff in this case must allege “injuries sustained by the buyer as a result of the breach of warranty.”
Dunham-Bush, Inc. v. Thermo-Air Service, Inc.,
Defendant’s Motion states that Plaintiff “has alleged no facts establishing privity with Wrigley. A plaintiff who purchases a product, but does not buy it directly from the defendant, is not in privity with that defendant.” DE 20 at 9. Defendant cites case law for the propositions that “to recover for the breach of a warranty, either express or implied, the plaintiff must be in privity of contract with the defendant,”
T.W.M. v. American Medical Sys.,
The privity requirement in Florida warranty claims is a moving target which depends on factors including whether the warranty is express or implied and the type of injury alleged. The Florida Supreme Court acknowledged that “warranty law in Florida has become filled with inconsistencies and misapplications in the judiciary’s attempt to provide justice to the injured consumer.”
West v. Caterpillar Tractor Co.,
After review of relevant case law, the Court makes the following observations. First, several Florida cases discussing warranty claims under the Magnuson-Moss Warranty Act, 15 U.S.C. § 2301
et seq.
(“MMWA”), have dismissed implied warranty claims against a manufacturer for lack of privity while allowing exprеss warranty claims to go forward.
See Mesa v. BMW of North America,
As mentioned, Plaintiff relies heavily on the
Hoskins
case, which allowed an implied warranty case to go forward despite a lack of privity. Although the
West
and
Kramer
decisions have scaled back the precedential value of
Hoskins
in implied warranty eases, those cases did not address express warranty cases. The Flоrida Supreme Court’s reasoning in
Hoskins
is particularly apt to the circumstances of this case. In
Hoskins,
a case involving a mislabeled seed, the Florida Supreme Court found “it would be utterly unsound and unfair” to hold that the plaintiff “could not recover from the one who knew the origin and history of the seed, simply because the farmer got them direct from retailer who knew no more about them than he.”
Id.
Many states have done away with the privity requirement in cases involving a manufacturer’s express warranty.
See, e.g., Kinlaw v. Long Mfg. N. C., Inc.,
The privity bound procedure whereby the purchaser claims against the retailer, the retailer against the distributor, and the distributor, in turn, against the manufacturer, is unnecessarily expensive and wasteful. We find no reason to inflict this drain on the court’s time and the litigants’ resources when there is an express warranty directed by its terms to none other than the plaintiff purchaser.
Id.
The Court need not resolve the issue of whether privity is ever required for express warranty claims under Florida law. Rather, the Court finds that, given the particular facts of this case, the analysis here is relatively straight-forward. First, this case is not similar to T.W.M. or Stearman. In each of those cases, whether it be a doctor installing an implant or a computer salesman, it could be assumed that the end-purchaser might expect the seller or “middle man” to have relevant knowledge, or even expertise, regarding the manufacturer’s product. Here, it defies common sense to argue that purchasers of Eclipse gum presumed that the cashier at the local convenience store is familiar with the scientific properties of MBE. Second, it is significant that the express warranty the manufacturer allegedly breached is contained on the packaging of Eclipse gum. Compl. ¶ 14. Moreover, the Complaint alleges that Plaintiff relied on the warranty when purchasing the gum. Id. ¶ 8. Accordingly, the Court finds that Plaintiff states a valid claim for breach of express warranty.
IV. CONCLUSION
For the foregоing reasons, it is hereby ORDERED AND ADJUDGED as follows:
1. Defendant’s Motion to Dismiss [DE 20] is DENIED.
2. The parties shall meet and confer regarding a schedule for filing a motion for class certification, including deadlines for the parties’ submissions and necessary discovery. By October 14, 2009, the parties shall file proposed schedule regarding the same.
Notes
. The Court notes that any future addenda of unpublished authorities need only include authorities that are not available on either Lexis or Westlaw.
. According to the Complaint, "[t]he NAD describes itself as the advertising industry's self-regulatory forum, whose purpose is to foster truth and accuracy in national advertising.” Compl. ¶ 42.
. Defendant argues that the Complaint fails under the Supreme Court decisions of
Twombly
and
Ashcroft v. Iqbal,
— U.S. —,
.
See also Tolliver,
